Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.40M | $76.0M | 11.81% | +614.6K | 2026-06-30 |
| Redmile Group, LLC | 4.37M | $52.0M | 8.07% | -- | 2026-06-30 |
| STATE STREET CORP | 2.97M | $35.0M | 5.49% | +239.7K | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.21M | $26.0M | 4.09% | -1.34M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.11M | $25.0M | 3.89% | +100.4K | 2026-06-30 |
| MORGAN STANLEY | 1.95M | $23.0M | 3.61% | -112.9K | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 1.42M | $17.0M | 2.62% | -418.0K | 2026-06-30 |
| AQR CAPITAL MANAGEMENT LLC | 1.38M | $16.0M | 2.54% | +326.6K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.36M | $16.0M | 2.50% | +336.7K | 2026-06-30 |
| MARSHALL WACE, LLP | 1.28M | $15.0M | 2.37% | +1.06M | 2026-06-30 |
